These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7120069)

  • 21. Effects of dihydroquinidine on in vitro and in vivo quinidine disposition.
    Ueda CT
    Biochem Pharmacol; 1980 Mar; 29(5):737-40. PubMed ID: 20227949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacokinetics and pharmacodynamics of quinidine and 3-hydroxyquinidine.
    Wooding-Scott RA; Smalley J; Visco J; Slaughter RL
    Br J Clin Pharmacol; 1988 Oct; 26(4):415-21. PubMed ID: 3190991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood collection techniques, heparin and quinidine protein binding.
    Kessler KM; Leech RC; Spann JF
    Clin Pharmacol Ther; 1979 Feb; 25(2):204-10. PubMed ID: 759074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cimetidine on quinidine distribution in rats.
    Shibasaki S; Komoriya K; Gon S; Matsuura Y; Nishigaki R; Umemura K
    J Pharmacobiodyn; 1987 Dec; 10(12):719-26. PubMed ID: 3451957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinidine pharmacokinetics in patients with cirrhosis or receiving propranolol.
    Kessler KM; Humphries WC; Black M; Spann JF
    Am Heart J; 1978 Nov; 96(5):627-35. PubMed ID: 263396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics and dynamics of quinidine-N-oxide in healthy subjects.
    Ha HR; Vozeh S; Uematsu T; Guentert TW; Follath F
    Clin Pharmacol Ther; 1987 Sep; 42(3):341-5. PubMed ID: 3621790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of increased plasma protein binding on the disposition of quinidine in turpentine-treated rats.
    Sugihara N; Furuno K; Kita N; Murakami T; Yata N
    Biol Pharm Bull; 1993 Jan; 16(1):63-7. PubMed ID: 8369755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing the apparent protein binding of quinidine.
    Guentert TW; Oie S
    J Pharm Sci; 1982 Mar; 71(3):325-8. PubMed ID: 7069591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the disposition of total and unbound sulfisoxazole after single and multiple dosing.
    Oie S; Gambertoglio JG; Fleckenstein L
    J Pharmacokinet Biopharm; 1982 Apr; 10(2):157-72. PubMed ID: 7120046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide.
    Giacomini KM; Swezey SE; Turner-Tamiyasu K; Blaschke TF
    J Pharmacokinet Biopharm; 1982 Feb; 10(1):1-14. PubMed ID: 7069575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of quinidine on digoxin distribution and elimination in guinea pigs.
    Sato J; Sawada Y; Iga T; Hanano M
    J Pharm Sci; 1983 Oct; 72(10):1137-41. PubMed ID: 6644558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of effect of cimetidine on the metabolism of quinidine: effect on renal clearance.
    Hardy BG; Schentag JJ
    Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):388-91. PubMed ID: 3220613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between the ocular and systemic disposition of flurbiprofen: the effect of altered protein dynamics at steady state.
    Tang-Liu DD; Liu S
    J Pharmacokinet Biopharm; 1987 Aug; 15(4):387-97. PubMed ID: 3681666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacokinetics of quinidine.
    Ochs HR; Greenblatt DJ; Woo E
    Clin Pharmacokinet; 1980; 5(2):150-68. PubMed ID: 6988137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical implication of changing unbound quinidine levels.
    Kessler KM; Wozniak PM; McAuliffe D; Terracall E; Kozlovskis P; Mahmood I; Zaman L; Trohman RG; Castellanos A; Myerburg RJ
    Am Heart J; 1989 Jul; 118(1):63-9. PubMed ID: 2741797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of alpha 1-acid glycoprotein on quinine and quinidine disposition in the rat isolated perfused liver preparation.
    Mansor SM; Ward SA; Edwards G; Hoaksey PE; Breckenridge AM
    J Pharm Pharmacol; 1991 Sep; 43(9):650-4. PubMed ID: 1685525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased plasma binding and decreased blood cell binding of quinidine in blood from anuric rats.
    Fremstad D
    Acta Pharmacol Toxicol (Copenh); 1977 Aug; 41(2):148-60. PubMed ID: 579054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in the binding of quinine and quinidine to plasma proteins.
    Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
    Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males.
    Karbwang J; Davis TM; Looareesuwan S; Molunto P; Bunnag D; White NJ
    Br J Clin Pharmacol; 1993 Mar; 35(3):265-71. PubMed ID: 8471402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue distribution of prednisolone in the rabbit.
    Khalafallah N; Jusko WJ
    J Pharmacol Exp Ther; 1984 Jun; 229(3):719-25. PubMed ID: 6726655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.